ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Leveraging Viscosity to Unlock the Osteogenic Potential of BMP-2 Mimetic DWIVA.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Intelligent design and application of molecular recognition hydrogels in tissue engineering.Materials today. Bio · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Growth factor mimetics offer great potential for osteogenic biomaterials; yet, their use remains limited, likely due to an incomplete understanding of the effects of the microenvironment on their activity. The extracellular matrices (ECMs) where growth factors are presented in vivo are viscoelastic environments, where dynamic receptor-ligand interactions drive cellular responses. Here, supported lipid bilayers of varying viscosity are used as 2D dynamic ECM models, where the bone morphogenetic 2 (BMP-2) mimetic DWIVA is presented to mesenchymal stem cells alongside the adhesive peptide RGD. DWIVA is demonstrated to have no impact on mechanotransductive processes, including actin organisation, focal adhesion formation and YAP localisation, which are exclusively controlled by viscosity via RGD. Interestingly, DWIVA promotes osteogenic markers' expression only on a viscous bilayer, through a process that involves non-canonical BMP-2 pathways; on a mobile bilayer or on a static control, it lacks osteogenic activity. Crucially, osteogenesis is accompanied by a translocation of BMP receptor 1a to the cell edge, where it colocalises with focal adhesions. Our ECM models hence reveal that both a viscosity-enabled threshold of cell-generated forces and a dynamic environment are necessary to harness the osteogenic potential of DWIVA, uncovering key microenvironment properties for the design of DWIVA-based biomaterials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.